Hôpital Nord

Marseille 13915

0 studies enrolling now · 8 studies all time

What they study most

Advanced Lung Cancer, Asthma, Carcinoma, Non-Small-Cell Lung, Early Breast Cancer, ICD Replacement or Upgrade, Inappropriate Shocks From Implanted Defibrillator, Indolent Systemic Mastocytosis, Lung Cancer, Metastatic Lung Cancer, NSCLC, Non-Small Cell Lung Cancer, Patients Implanted With a Pacemaker

Studies at this site

• Registry of Asthma Patients Initiating DUPIXENT® — Completed
• A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC — Running, not enrolling
• Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients) — Running, not enrolling
• Observational Study on Inappropriate Therapies — Status unconfirmed
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed
• A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations — Stopped early
• A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. — Status unconfirmed
• Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers — Completed